• Home
  • NEW DAY MEDICINE
  • 9 (47) 2022
  • 76 — 9 (47) 2022 — Keldiyorova Z.D., Narzullaev N.U., Mirzoeva M.R., Nurova O.K., EVALUATION OF THE CLINICAL EFFECTIVENESS OF IMMUNOTROPIC TREATMENT IN CHILDREN WITH INFECTIOUS MONONUCLEOSIS

76 — 9 (47) 2022 — Keldiyorova Z.D., Narzullaev N.U., Mirzoeva M.R., Nurova O.K., EVALUATION OF THE CLINICAL EFFECTIVENESS OF IMMUNOTROPIC TREATMENT IN CHILDREN WITH INFECTIOUS MONONUCLEOSIS

EVALUATION OF THE CLINICAL EFFECTIVENESS OF IMMUNOTROPIC TREATMENT IN CHILDREN WITH INFECTIOUS MONONUCLEOSIS

Keldiyorova Z.D.,Bukhara State Medical Institute

Narzullaev N.U.,Bukhara State Medical Institute

Mirzoeva M.R., Bukhara State Medical Institute

Nurova O.K.,Bukhara State Medical Institute

Resume

Treatment of patients with infectious mononucleosis, according to doctors, is a difficult task. This is due to the variety of clinical manifestations, which are based on the lymphoproliferative syndrome, manifested by lymphadenopathy, tonsillitis, hepatosplenomegaly. After primary infection with herpesviruses, their persistence in the body is observed. It may not manifest itself clinically, but it can reactivate herpesviruses and this leads to the development of various clinical forms, such as chronic recurrent herpesvirus infection, oncological lymphoproliferative process, autoimmune diseases, chronic fatigue syndrome.

The authors conducted a scientific and analytical study evaluating the clinical efficacy of immunotropic treatment in children with infectious mononucleosis, after treatment in children with infectious mononucleosis, cellular immune response in children who underwent immunotropic treatment, normalization of T-cell immunity, as well as with the development of pathological processes, decisive for the outcome of the disease is the state of activated lymphocytes.

Keywords: infectious mononucleosis, immunomodulator, herpeviruses, hepatosplenomegaly

First page

449

Last page

455

For citation: Keldiyorova Z.D., Narzullaev N.U., Mirzoeva M.R., Nurova O.K., EVALUATION OF THE CLINICAL EFFECTIVENESS OF IMMUNOTROPIC TREATMENT IN CHILDREN WITH INFECTIOUS MONONUCLEOSIS //New Day in Medicine 9 (47)2022 449-455 https://l.clck.bar/4665d

LIST OF REFERENCES:

  1. Антонова М. В., Любимцева О. А., Кашуба Э. А. Клинические картина инфекционного мононуклеоза Эпштейна-Барр вирусной этиологии в возрастном аспекте // Академический журнал Западной Сибири. – 2014. – Т. 10. – № 5. -С. 65-66.
  2. Арова А. А., Крамарь Л. В., Алюшин А. М., Карпухина О. А. “Клинические маски” инфекционного мононуклеоза. Пути терапевтической коррекции // Волгоградский научно-медицинский журнал. – 2011. – № 2. – С. 26-31.
  3. Барычева Л.Ю., Голубева М.В., Волкова А.В. Показатели адабтивного иммунитета у детей с инфекционным мононуклеозом, обусловленным вирусом Эпштейна –Барра // Кубанский научный медицинский вестник. 2012. №2. -С.30-33.
  4. Гордеец А.В., Савина О.Г., Бениова С.Н., Черникова А.А. Этиология, иммунологические варианты инфекционного мононуклеоза и способ их коррекции // Экспериментальная и клиническая фармакология. – 2011. – Т. 74. – № 11. – С. 29-32.
  5. Гурцевич В.Э., Степина В.Н., Сенюта Н.Б. Гуморальный иммунный ответ к вирусу Эпштейна-Барр в диагностике рака носоглотки (обзор литературы и 30-летний опыт собственных исследований) // Вестник РОНЦ им. Н. Н. Блохина РАМН. – 2011. – Т. 22. – № 2. – С. 20-30.
  6. Balfour H.H., Odumade O.A. Behavioral,virologic,and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus. Infection in university students // J. Infect.Dis.-2013.Vol.207.-P.80-88.
  7. Bieging K. T., Amick A. C., Longnecker R. Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis // Proc. Natl. Acad. Sci. USA. 2009. Vol. 7. -P. 17945-17950.
  8. Keldiyorova Z.D. Immunological features of infectious mononucleosis epstein-barr virus etiology in children // New Day in Medicine 2(34)2021 231-234 https://cutt.ly/fnoLBGB
  9. Келдиёрова З.Д. Состояние иммунной системы у детей с инфекционным мононуклеозом и обоснование иммунокорригируюшей терапии. // Central Asian Journal of Medical and Natural Sciences. 2021.
  10. Keldiyorova Z.D., Ostonova G.S., Mirzoeva M.R., Narzullaev N.U. State of the immune system in children with infectious mononucleosis // New Day in Medicine 1(33)2021 283-290 https://cutt.ly/6x8DMt3